Hydrogel-Based Controlled Drug Delivery for Cancer Treatment: A Review

Mol Pharm. 2020 Feb 3;17(2):373-391. doi: 10.1021/acs.molpharmaceut.9b01020. Epub 2020 Jan 7.

Abstract

As an emerging drug carrier, hydrogels have been widely used for tumor drug delivery. A hydrogel drug carrier can cause less severe side effects than systemic chemotherapy and can achieve sustained delivery of a drug at tumor sites. In addition, hydrogels have excellent biocompatibility and biodegradability and lower toxicity than nanoparticle carriers. Smart hydrogels can respond to stimuli in the environment (e.g., heat, pH, light, and ultrasound), enabling in situ gelation and controlled drug release, which greatly enhance the convenience and efficiency of drug delivery. Here, we summarize the different sizes of hydrogels used for cancer treatment and their related delivery routes, discuss the design strategies for stimuli-responsive hydrogels, and review the research concerning smart hydrogels reported in the past few years.

Keywords: cancer; drug delivery systems; hydrogel; stimuli-responsive materials.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Drug Carriers / administration & dosage*
  • Drug Delivery Systems / methods*
  • Drug Liberation
  • Humans
  • Hydrogels / administration & dosage*
  • Hydrogen-Ion Concentration
  • Light
  • Magnetic Fields
  • Mice
  • Neoplasms / drug therapy*
  • Oxidation-Reduction
  • Stimuli Responsive Polymers / administration & dosage*
  • Temperature
  • Treatment Outcome
  • Ultrasonic Waves

Substances

  • Drug Carriers
  • Hydrogels
  • Stimuli Responsive Polymers